Press Releases & Announcements
-
Membrane Raft Redox Signaling Contributes to Visfatin-Induced Inflammation and Kidney Damage
PRESS RELEASE: A new research paper was published in Aging’s Volume 15, Issue 22, entitled, “Contribution of membrane raft redox signalling to visfatin-induced inflammasome activation and podocyte injury.”
-
Aging Modulates Extracellular Vesicles of Epidermal Keratinocytes
PRESS RELEASE: A new research paper was published on the cover of Aging’s Volume 15, Issue 22, entitled, “Chronological aging impacts abundance, function and microRNA content of extracellular vesicles produced by human epidermal keratinocytes.” … continue reading
-
Anti-Aging Effects of 1,5-Anhydro-D-Fructose on Brain Diseases via AMPK Activation
PRESS RELEASE: A new research paper was published in Aging’s Volume 15, Issue 21, entitled, “1,5-anhydro-D-fructose induces anti-aging effects on aging-associated brain diseases […]” … continue reading
-
Mitochondria-Targeting Antibiotics Extend Lifespan in C. Elegans
PRESS RELEASE: A new research paper was published in Aging’s Volume 15, Issue 21, entitled, “Antibiotics that target mitochondria extend lifespan in C. elegans.” … continue reading
Aging: Volume 15, Issue 22
-
Chronological aging impacts abundance, function and microRNA content of extracellular vesicles produced by human epidermal keratinocytes
The disturbance of intercellular communication is one of the hallmarks of aging. The goal of this study is to clarify the impact of chronological aging on extracellular vesicles (EVs), a key mode of communication in mammalian tissues.
Aging Blogs
ABOUT AGING-US.NET
Aging-US.net features interviews and testimonials from the distinguished network of authors who continue to publish their research with Aging (Aging-US)—a twice-monthly, traditional, peer-reviewed journal with open access, covering all areas of research on aging, including age-related diseases, such as cancer.
The journal aims to promote treatment of age-related diseases by slowing down aging, validation of anti-aging drugs by treating age-related diseases and prevention of cancer by inhibiting aging. Cancer and COVID-19 are age-related diseases.
Impact Journals, the publisher of Aging (Aging-US), meets the standards of the Wellcome Trust Publisher Requirements and was included in the Wellcome Trust List of Compliant Publishers. Read about our rigorous Scientific Integrity Process.
To learn more, please visit Aging-US.com and connect with us:
Facebook | Twitter | LinkedIn | YouTube | Instagram | Pinterest | SoundCloud
